XERF™ is a non-invasive treatment from CYNOSURE LUTRONIC which delivers multifrequency radiofrequency energy (both 6.78 MHz and 2MHz) to reach various tissue depths without any incisions or needles. This is the latest non-surgical treatment from South Korea and is the world’s first multi-frequency monopolar radiofrequency (RF) treatment. RF energy delivers an electrical current that targets collagen in your dermis and fibrous septa in your subcutaneous fat, resulting in more collagen production (neocollagenesis), more elastin production (neoelastinogenesis), and reduction of laxity.
XERF™ is equipped with advanced cooling, energy delivery, depth-control, and real-time temperature-monitoring, which allows it to deliver more energy than past devices for better results, while ensuring minimal patient discomfort and maximum safety without downtime. There are shallow, middle, and deep modes, to allow treatment tailored to different tissue depths. Results are both immediate and improve over time with dermal remodeling and strengthening of the fibro-septal network underneath your skin.
XERF™ received FDA-approval for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis in August 2025. In addition to the face and neck, XERF™ can also be applied to areas with skin such as the arms, breasts, abdomen, and thighs for the same effects of skin tightening and rejuvenation. XERF™ is best applied to patients with mild to moderate laxity/sagging skin and mild to moderate skin textural changes. A minimum of two treatments is recommended for best results, spaced at 4–6-week intervals.